Pharmaceutical

STAT+: FDA proposes changes to key approval pathway for...

The FDA issued new guidelines clarifying the way they plan to evaluate medical d...

STAT+: Acelyrin, a rare IPO success, stumbles in its fi...

Acelyrin, which raised more than $500 million in an IPO this year, ran into its ...

FDA approves updated Covid vaccines

The FDA announced Monday that it had greenlit two updated Covid-19 booster shots...

STAT+: Pharmalittle: Biden’s NIH nominee will get a hea...

President Biden’s nominee to lead NIH will get a hearing next month, perhaps tha...

As kids, they underwent a common test for UTIs. As adul...

As kids, they underwent a common test for UTIs. As adults, it haunts them as a t...

STAT+: Experts fear private equity will pour gas on car...

Cardiology is private equity’s latest fixation. Experts fear the financial inves...

Opinion: Doctors in the U.S. can learn a lot about advo...

Organized medicine in the United States has failed to meet its moment.

Janssen seeks EMA authorisation for urothelial cancer t...

Janssen has filed a marketing authorisation application with the European Medici...

Alexion and Verge enter AI-powered drug discovery deal

Alexion has entered into a partnership with Verge Genomics to detect new drug ta...

Sandoz partners with Samsung Bioepis to license Stelara...

The agreement allows Sandoz exclusive marketing rights for the inflammatory bowe...

Pharmaceutical Technology Excellence Awards 2023: Viedoc

Viedoc is a Category Award Winner for Innovation and Product Launches in the 202...

Verona Pharma’s ensifentrine inches closer to approval ...

The agency has set a PDUFA target action date to June 2024, with no current plan...

Why prefilled vial capacity is key to a competitive edg...

With many biopharma companies outsourcing for manufacturing support, how can you...

Signal: Kroger to pay up to $1.4bn to settle opioid cri...

Kroger's settlement, alongside the review of the Purdue Pharma bankruptcy case, ...

Coherus acquires immuno-oncology company Surface

Coherus BioSciences has concluded the acquisition of immuno-oncology (I-O) compa...

Grit Biotechnology secures funds for development of pip...

Grit Biotechnology has secured more than $60m in a Series B funding round to sup...